CD79A and neoplasm: Therefore, we assessed the prevalence and level of antibodies against the main antigens of the EBV, i.e., EBVCA and EBNA1, both in IgA and IgG classes, depending on the clinicopathological parameters such as GS, risk group and tumor size (T).